Skip to main content

Cost-effective reimbursement analysis for medical technologies in Europe

Procedure coding, payment mechanism, reimbursement tariffs, policy, and HTA considerations in 14 EU countries

Learn more
fghjkjhb

White Paper: Reimbursement of Day Case Surgery Procedures in Europe

Explore strategic insights into opportunities and barriers for day case surgery reimbursement in Europe

Request free of charge
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

First revision of the new Swiss outpatient reimbursement system submitted for approval

On June 2, 2026, the OAAT AG and the tariff partners submitted the 2027 revision of the comprehensive outpatient reimbursement system to the Federal Council for approval. 

This revision is the first development of the new outpatient reimbursement system, which consists of the TARDOC catalog of individual service tariffs (version 1.5) and the outpatient flat rates (version 1.2), and came into effect in January 2026. The main focus of the first revision was on nuclear medicine, hand, maxillofacial, and pediatric surgery, and pathology for the outpatient flat rate system, and on pediatric medicine, as well as emergency and urgent care, for TARDOC.

The system is subject to regular revisions. According to OAAT, a large portion of the extensive feedback and valid proposals received during the annual application process for the further development of the comprehensive outpatient system was incorporated directly into the currently submitted version.

The revised version is planned to come into force on January 1, 2027, if the Federal Council grants its approval. OAAT and the tariff partners are already working on the 2028 version.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.